| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3201963 | Journal of Allergy and Clinical Immunology | 2007 | 8 Pages |
Abstract
Recombinant hybrid Q2 is able to induce T-cell proliferation, thus evidencing a potential therapeutic effect. Its reduced IgE-binding capacity envisages an excellent safety profile.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Roberto PhD, Ignacio PhD, M. Carmen PhD, Angel MD, PhD, Amparo MD, PhD, Carmen MD, Alberto PhD, Juan A. PhD,